Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday

Benzinga · 1d ago
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Monday.
Shares of Kyverna Therapeutics Inc (NASDAQ:KYTX) rose sharply during Monday's session after the company announced topline data from KYSA-8.
The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2 trial of mivocabtagene autoleucel (miv-cel, formerly KYV-101) in stiff person syndrome (SPS).
Miv-cel is a fully human, autologous CD19-targeting CAR T-cell therapy with CD28 co-stimulation.
Kyverna Therapeutics shares jumped 31% to $11.49 on Monday.
Here are some other big stocks recording gains in today’s session.
- Beneficient (NASDAQ:BENF) gained 29.3% to $6.21.
- Immunome Inc (NASDAQ:IMNM) surged 25.5% to $24.56 after announcing positive topline results from Phase 3 RINGSIDE trial of Varegacestat in patients with Desmoid Tumors.
- Falcon’s Beyond Global Inc (NASDAQ:FBYD) gained 14% to $12.83.
- XBP Global Holdings Inc (NASDAQ:XBP) surged 11.5% to $6.39.
- Almonty Industries Inc (NASDAQ:ALM) gained 9.1% to $7.38 as the company announced voluntary withdrawal of base shelf prospectus and registration statement.
- Ur-Energy Inc (NYSE:URG) gained 8.6% to $1.39.
- NovaBay Pharmaceuticals Inc (NYSE:NBY) shares jumped 7.1% to $3.00.
- AXT Inc (NASDAQ:AXTI) rose 7.1% to $15.88.
- Olema Pharmaceuticals Inc (NASDAQ:OLMA) jumped 6.8% to $35.30.
- Silvercorp Metals Inc (NYSE:SVM) gained 6.4% to $8.65.
- Standard Lithium Ltd (NYSE:SLI) surged 6.3% to $4.91.
- ZIM Integrated Shipping Services Ltd (NYSE:ZIM) gained 4.8% to $19.64.
Read This Next:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.